Approaches to Improving Drug Bioavailability for Complex Molecules 2026
Bioavailability enhancement has become a central focus in drug development, especially for complex molecules such as poorly soluble small molecules, peptides, and biologics. In 2026, ensuring that an active pharmaceutical ingredient (API) reaches systemic circulation efficiently is crucial for achieving therapeutic outcomes, reducing dosage, and minimising patient variability. Poor bioavailability can result from low solubility, […]